NO303783B1 - Substituted aminophosphonate derivatives and pharmaceutical preparations thereof - Google Patents
Substituted aminophosphonate derivatives and pharmaceutical preparations thereofInfo
- Publication number
- NO303783B1 NO303783B1 NO930768A NO930768A NO303783B1 NO 303783 B1 NO303783 B1 NO 303783B1 NO 930768 A NO930768 A NO 930768A NO 930768 A NO930768 A NO 930768A NO 303783 B1 NO303783 B1 NO 303783B1
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- pharmaceutical preparations
- aminophosphonate derivatives
- aminophosphonate
- derivatives
- Prior art date
Links
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5537—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to novel aminophosphonate derivatives substituted in alpha position by phenol groups, of formula (I): <CHEM> in which: X<1>, X<2>, X<3>, R<1>, R<2>, A, B, Z and n are defined in Claim 1, as well as their preparations and the pharmaceutical compositions comprising them.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH704/92A CH683996A5 (en) | 1992-03-05 | 1992-03-05 | aminophosphonates substituted derivatives, process for their preparation and pharmaceutical compositions containing them. |
Publications (3)
Publication Number | Publication Date |
---|---|
NO930768D0 NO930768D0 (en) | 1993-03-03 |
NO930768L NO930768L (en) | 1993-09-06 |
NO303783B1 true NO303783B1 (en) | 1998-08-31 |
Family
ID=4193232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO930768A NO303783B1 (en) | 1992-03-05 | 1993-03-03 | Substituted aminophosphonate derivatives and pharmaceutical preparations thereof |
Country Status (17)
Country | Link |
---|---|
US (1) | US5424303A (en) |
EP (1) | EP0559079B1 (en) |
JP (1) | JPH0649083A (en) |
KR (1) | KR930019685A (en) |
AT (1) | ATE156829T1 (en) |
AU (1) | AU662957B2 (en) |
CA (1) | CA2091031A1 (en) |
CH (1) | CH683996A5 (en) |
DE (1) | DE69312984T2 (en) |
DK (1) | DK0559079T3 (en) |
ES (1) | ES2108772T3 (en) |
FI (1) | FI930974A (en) |
GR (1) | GR3025268T3 (en) |
NO (1) | NO303783B1 (en) |
NZ (1) | NZ247056A (en) |
SG (1) | SG43831A1 (en) |
ZA (1) | ZA931473B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4433244A1 (en) * | 1994-09-19 | 1996-03-28 | Hoechst Ag | Aminomethylphosphonic and aminomethylphosphinic acid derivatives and their use for the treatment of degenerative joint diseases |
DE19502209A1 (en) * | 1995-01-25 | 1996-08-01 | Hoechst Ag | Phosphonoacetic acid derivatives and their use for the treatment of degenerative joint diseases |
CH690264A5 (en) * | 1995-06-30 | 2000-06-30 | Symphar Sa | aminophosphonates substituted derivatives, their preparation process and their use for preparing pharmaceutical compositions. |
GB9626616D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626536D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626615D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
JP3418322B2 (en) | 1997-08-28 | 2003-06-23 | 日本電信電話株式会社 | IC card with use status display function and IC card system |
DE19748659A1 (en) * | 1997-11-04 | 1999-05-06 | Hoechst Ag | Aminophosphonium group-containing crosslinked copolymers for medical uses |
PL205184B1 (en) | 1998-09-09 | 2010-03-31 | Metabasis Therapeutics Inc | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
CA2387394C (en) | 1999-10-27 | 2009-08-18 | Teva Pharmaceutical Industries, Ltd. | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
JP2004513891A (en) | 2000-09-27 | 2004-05-13 | アイレックス オンコロジー リサーチ エス.エイ. | α-substituted β-aminoethyl phosphonate |
US20030114421A1 (en) * | 2000-09-27 | 2003-06-19 | Phan Hieu Trung | Alpha-substituted beta-aminoethyl phosphonate derivatives |
GB0025849D0 (en) | 2000-10-23 | 2000-12-06 | Smithkline Beecham Plc | Novel compounds |
ES2530579T3 (en) | 2003-12-23 | 2015-03-03 | Abraxis Bioscience Llc | Propofol analogues, preparation procedure, and use procedures |
JP4824968B2 (en) * | 2005-08-18 | 2011-11-30 | 株式会社クレハ | Phosphonic acid derivatives and acid addition salts thereof, and agricultural and horticultural disease control agents using the same |
JP2007318972A (en) | 2006-05-29 | 2007-12-06 | Jtekt Corp | Electric motor and electrically powered steering system |
CN101003548B (en) * | 2006-12-12 | 2010-09-08 | 中国林业科学研究院林产化学工业研究所 | Rosinyl diterpene modified alpha - phosphoramidate, preparation method, and application for anti tumors |
EP2854539A4 (en) * | 2012-05-14 | 2016-03-09 | Univ Kansas | Phosphonate derivatives for treatment of alzheimer's disease |
CN104987350B (en) * | 2015-01-29 | 2017-12-05 | 贵州大学 | One kind has chiral alpha aminophosphonate compound and preparation and the application of the heterocycle containing benzothiazole of antiviral activity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1200679B (en) * | 1964-04-25 | 1965-09-09 | Agfa Ag | Light-sensitive material with embedded developer substance |
GB1298199A (en) * | 1969-02-13 | 1972-11-29 | Curwen & Newberry Ltd | Improvements in or relating to boilers or fluid heaters |
US4144224A (en) * | 1976-11-26 | 1979-03-13 | Ciba-Geigy Corporation | Phosphonate stabilizers |
CH675422A5 (en) * | 1988-03-31 | 1990-09-28 | Symphar Sa |
-
1992
- 1992-03-05 CH CH704/92A patent/CH683996A5/en not_active IP Right Cessation
-
1993
- 1993-02-25 EP EP93102934A patent/EP0559079B1/en not_active Expired - Lifetime
- 1993-02-25 DE DE69312984T patent/DE69312984T2/en not_active Expired - Fee Related
- 1993-02-25 AT AT93102934T patent/ATE156829T1/en not_active IP Right Cessation
- 1993-02-25 ES ES93102934T patent/ES2108772T3/en not_active Expired - Lifetime
- 1993-02-25 DK DK93102934.2T patent/DK0559079T3/en not_active Application Discontinuation
- 1993-02-25 SG SG1996001674A patent/SG43831A1/en unknown
- 1993-02-26 US US08/024,731 patent/US5424303A/en not_active Expired - Lifetime
- 1993-03-02 ZA ZA931473A patent/ZA931473B/en unknown
- 1993-03-03 NZ NZ247056A patent/NZ247056A/en unknown
- 1993-03-03 NO NO930768A patent/NO303783B1/en unknown
- 1993-03-04 FI FI930974A patent/FI930974A/en unknown
- 1993-03-04 AU AU33947/93A patent/AU662957B2/en not_active Ceased
- 1993-03-04 CA CA002091031A patent/CA2091031A1/en not_active Abandoned
- 1993-03-05 KR KR1019930003335A patent/KR930019685A/en not_active IP Right Cessation
- 1993-03-05 JP JP5069078A patent/JPH0649083A/en active Pending
-
1997
- 1997-11-05 GR GR970402906T patent/GR3025268T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0559079A1 (en) | 1993-09-08 |
ZA931473B (en) | 1993-09-23 |
DE69312984T2 (en) | 1998-03-12 |
GR3025268T3 (en) | 1998-02-27 |
US5424303A (en) | 1995-06-13 |
NZ247056A (en) | 1995-08-28 |
DE69312984D1 (en) | 1997-09-18 |
KR930019685A (en) | 1993-10-18 |
FI930974A (en) | 1993-09-06 |
ATE156829T1 (en) | 1997-08-15 |
SG43831A1 (en) | 1997-11-14 |
CA2091031A1 (en) | 1993-09-06 |
CH683996A5 (en) | 1994-06-30 |
NO930768L (en) | 1993-09-06 |
FI930974A0 (en) | 1993-03-04 |
AU662957B2 (en) | 1995-09-21 |
ES2108772T3 (en) | 1998-01-01 |
DK0559079T3 (en) | 1998-03-30 |
AU3394793A (en) | 1993-09-09 |
JPH0649083A (en) | 1994-02-22 |
EP0559079B1 (en) | 1997-08-13 |
NO930768D0 (en) | 1993-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO303783B1 (en) | Substituted aminophosphonate derivatives and pharmaceutical preparations thereof | |
DK77090D0 (en) | Immunomodulatory AZASPIRANS | |
FI943749A0 (en) | Phosphonooxymethyl ethers of taxane derivatives | |
BG92804A (en) | 4-BENZOYLISOXAZOLE DERIVATIVES | |
ATE107499T1 (en) | HAIR STRENGTHENING AGENT. | |
DK0539204T3 (en) | Antiviral 4-substituted-deoxy-2,3-didehydro derivatives of alpha-D-neuraminic acid | |
FI920023A0 (en) | HETEROARYLPIPERAZINFOERENINGAR SOM ANTIPSYKOTISKA AEMNEN. | |
DK0513675T3 (en) | New peptide compound and method of preparation thereof | |
NO922133D0 (en) | SUBSTITUTED DIAMINOPHALIMIDES AND ANALOGS | |
DK268289A (en) | CEPHEM RELATIONS AND PROCEDURES FOR PRODUCING THEREOF | |
FI881609A0 (en) | DIHYDROPYRIDINAMIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL. | |
DK0564358T3 (en) | 3-Aminochroman Spiro Derivatives, Methods of Preparation thereof and Pharmaceutical Compositions Containing Such | |
DK0937043T3 (en) | Substituted tetrahydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives | |
DK638787A (en) | ANTHRACYCLINE DERIVATIVES, THEIR PREPARATION AND USE | |
NO903291L (en) | PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES. | |
NO842345L (en) | HEKSAHYDROPYRROLO (2,1-a) isoquinoline derivatives. | |
DE69222143D1 (en) | Indane derivatives | |
DK0418990T3 (en) | 13-bromo- and 13,14-dibromo-ergolines, their preparation and use in pharmaceuticals | |
DK0538517T3 (en) | New organotin compounds with antitumor activity and antitumor agents | |
DK0552631T3 (en) | Alpha-aryl-alpha-hydroxy-beta-imidazolinyl propionsyreamider | |
BR9915898A (en) | Compounds, pharmaceutical composition, and use of a compound |